Brand-name supply shortages and high costs create barriers for many patients
These benefits highlight why GLP-1 medications have become an important option for some women navigating the metabolic changes that often accompany menopause
During the review, the committee will likely consider: The extensive body of published research on GHK-Cu (decades of studies) Safety data for both injectable and topical routes The clinical rationale for copper peptide therapy in anti-aging and wound healing Quality control considerations for compounding GHK-Cu formulations Public comments from patients, dermatologists, anti-aging practitioners, and pharmacies Given GHK-Cu's long history of use and substantial research base, many in the peptide therapy community are cautiously optimistic about a positive PCAC recommendation particularly for the topical route
International shipping to 30+ countries
Importantly, with the advent of more potent GLP-1 receptor agonists like semaglutide, it is crucial to study these newer medications individually rather than grouping them with older drugs in the same class, as their effects may differ significantly, she added